Advanced Technology Program NIST Home Page

Track 1: BIOTECHNOLOGY

DNA Diagnostics

Biosensor Technology

Plant Biotechnology

New Frontiers in Biotechnology and the Role of the ATP

Proteomics

Return to Previous Page  Return to Program for 1999 ATP National Meeting

 

AGENDA:
New Frontiers in Biotechnology
and the Role of the
Advanced Technology Program
Presentations Received as of: November 30, 1999
Wednesday, November 17, 1999
8:30-8:45 a.m. Mrunal Chapekar, Program Manager, Chemistry and Life Sciences Office, ATP
Introduction and Welcome
8:45-9:25 a.m. David Mooney, University of Michigan, Ann Arbor, MI
Novel Biomaterials for Tissue Engineering and Drug Delivery View Presentation
9:25-10:05 a.m. Jon Wolff , M.D., University of Wisconsin -Madison, Madison, WI
Challenges to the Commercialization of Gene Therapy View Presentation
10:05-10:45 a.m. Roger Pedersen, Ph.D, University of California, San Francisco, CA
Embryonic Stem Cells: In Vitro Differentiation and Therapeutic Potential View Presentation
10:45 – 11:00 a.m.   Coffee Break
11:00 – 11:40 a.m. Breakout Sessions
11:40 – 11:55 a.m. Session Summaries and Discussion
11:55 -12.00 p.m. Wrap Up

Go to Top of Page  Go to top of document

ATP Home Page NIST Home Page
ATP website comments: webmaster-atp@nist.gov • Technical ATP inquiries: InfoCoord.ATP@nist.gov

Privacy policy / security notice / accessibility statement • NIST Disclaimer • NIST Information Quality Standards

NIST is an agency of the U.S. Commerce Department's Technology Administration.